Özcan Pırıltı, Düzgün Özgül
Department of General Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University, 34098 Istanbul, Turkey.
Department of Surgical Oncology, İstanbul Umraniye Training and Research Hospital, University of Health Sciences, 34766 Istanbul, Turkey.
J Pers Med. 2024 Aug 29;14(9):916. doi: 10.3390/jpm14090916.
Colorectal cancer peritoneal carcinomatosis (CRC PC) necessitates preoperative assessment of inflammatory markers to predict postoperative outcomes and guide treatment. This study aims to evaluate the prognostic value of preoperative Neutrophil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) in predicting complications for CRC PC patients undergoing surgery.
Calculating NLR, PLR, and MPV from patient data: NLR = absolute neutrophil count/total lymphocyte count, PLR = total lymphocyte count/total platelet count × 100, and MPV = platelet crit (PCT)/total platelet count.
The study included 196 CRC PC patients and found significant relationships between these markers and overall survival (OS). Patients with an NLR of 3.77 had a median OS of 22.1 months, compared to 58.3 months for those with lower NLR (HR 2.7, 95% CI 1.1-5.3, < 0.001).
For CRC PC patients undergoing CRS+HIPEC, preoperative assessment of NLR, PLR, and MPV can serve as independent prognostic markers for OS. Incorporating these markers into preoperative evaluations may improve patient selection and outcome prediction.
结直肠癌腹膜转移(CRC PC)需要对炎症标志物进行术前评估,以预测术后结果并指导治疗。本研究旨在评估术前中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和平均血小板体积(MPV)对接受手术的CRC PC患者并发症预测的预后价值。
根据患者数据计算NLR、PLR和MPV:NLR = 中性粒细胞绝对计数/淋巴细胞总数,PLR = 淋巴细胞总数/血小板总数×100,MPV = 血小板压积(PCT)/血小板总数。
该研究纳入了196例CRC PC患者,发现这些标志物与总生存期(OS)之间存在显著相关性。NLR为3.77的患者中位OS为22.1个月,而NLR较低的患者为58.3个月(HR 2.7,95%CI 1.1 - 5.3,<0.001)。
对于接受CRS+HIPEC的CRC PC患者,术前评估NLR、PLR和MPV可作为OS的独立预后标志物。将这些标志物纳入术前评估可能会改善患者选择和结果预测。